Across TCGA pan-cancer cohorts, OR51B3P RNA differs between tumor and matched normal tissue in 2 of 18 cancer types tested, making tumor–normal expression one of OR51B3P’s most consistent transcriptional readouts.

The strongest signal is observed in kidney renal clear cell carcinoma (KIRC), where OR51B3P RNA is more highly expressed in tumor relative to normal tissue. In most cancer types OR51B3P is over-expressed in tumor, although a few such as KICH show the opposite, repressed pattern.

KIRC and KICH are the cancer types where OR51B3P tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in OR51B3P RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
KIRC	Female	III,IV	+0.025	.028	4	view →
KICH	All	II,III,IV	−0.023	.033	2	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 2 strongest of 2 lineages.

Exploration

Same gene, other analysis: OR51B3P RNA expression & survival · all OR51B3P data types